Religare to sell stake in Religare Health Insurance for Rs 1,040 cr

IANS  |  New Delhi 

Ltd (REL) on Sunday announced it will sell its entire 80 per cent stake in Religare Health to a consortium of investors led by private True North Managers for an estimated Rs 1,040 crore.

"The company has entered into definitive agreements with a consortium of investors led by True North Managers, an India based private (formerly known as India Value Fund Advisors), to divest its entire stake in Religare Health Company Ltd (RHI)," said in a stock exchange filing.

"This transaction values Religare Health at Rs 1,300 crore and currently has 80 per cent shareholding on a fully diluted basis in the company," it said.

"The consortium of investors includes Metaffinity Pvt Ltd (owned and controlled by India Value Fund), Shree Nirman Ltd (a Puneet Dalmia Group Company) and Faering Capital India Evolving Fund II," it added.

said the transaction marks the single largest investment in a standalone health company in India.

Commenting on the development, Group CEO Maninder Singh said: "This sale is a continuation of REL's strategy to consolidate and focus on its core businesses. We are confident that RHI will continue on its high growth trajectory under the new ownership."

Since commercial launch in July 2012, RHI has emerged as a leading standalone health insurer in India, the statement said

The company has reported gross written premium of Rs 503 crore for the year ended March 31, 2016.

--IANS

bc/dg

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Religare to sell stake in Religare Health Insurance for Rs 1,040 cr

Religare Enterprises Ltd (REL) on Sunday announced it will sell its entire 80 per cent stake in Religare Health Insurance to a consortium of investors led by private equity fund True North Managers for an estimated Rs 1,040 crore.

Ltd (REL) on Sunday announced it will sell its entire 80 per cent stake in Religare Health to a consortium of investors led by private True North Managers for an estimated Rs 1,040 crore.

"The company has entered into definitive agreements with a consortium of investors led by True North Managers, an India based private (formerly known as India Value Fund Advisors), to divest its entire stake in Religare Health Company Ltd (RHI)," said in a stock exchange filing.

"This transaction values Religare Health at Rs 1,300 crore and currently has 80 per cent shareholding on a fully diluted basis in the company," it said.

"The consortium of investors includes Metaffinity Pvt Ltd (owned and controlled by India Value Fund), Shree Nirman Ltd (a Puneet Dalmia Group Company) and Faering Capital India Evolving Fund II," it added.

said the transaction marks the single largest investment in a standalone health company in India.

Commenting on the development, Group CEO Maninder Singh said: "This sale is a continuation of REL's strategy to consolidate and focus on its core businesses. We are confident that RHI will continue on its high growth trajectory under the new ownership."

Since commercial launch in July 2012, RHI has emerged as a leading standalone health insurer in India, the statement said

The company has reported gross written premium of Rs 503 crore for the year ended March 31, 2016.

--IANS

bc/dg

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22